ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2021 American Transplant Congress » Biomarkers, Immune Assessment and Clinical Outcomes

Date & Time:
None. Available on demand

Location: Virtual

Session Type: Poster Abstract

Meeting: 2021 American Transplant Congress

  • A Reliable Non Invasive Alternative to Surveillance Renal Allograft Biopsy

    R. Jain, S. Thaduri, V. Kumar, C. Kew, B. Julian, G. Towns, S. Ong, F. Ahmed, S. Mehta, G. Agarwal

  • AlloMap Kidney Gene Expression Profiling Discriminates Rejection from Immuno-Quiescence in Renal Transplant Recipients

    E. Akalin1, A. Djamali2, H. Xu3, X. Jin3, R. N. Woodward3, S. Dholakia3, J. S. Bromberg4

  • Analysis of Single Cell RNA Sequencing Data to Define Biomarkers of Human Liver Immune Tolerance

    B. Rocque1, A. Barbetta1, P. Singh1, C. Goldbeck1, D. G. Helou2, E. Loh3, N. Ung4, J. S. Lee4, O. Akbari2, J. Emamaullee1

  • Analysis of the Difference of the Monitoring Results of Tcr High Variable Area in Renal Transplant Recipients After Treatment with Different Immune Induction Schemes

    P. Tian, F. Han, M. Dou, B. Zheng, G. Deng, X. Ding, W. Xue

  • Association of Immune Cell Markers with Adverse Outcomes in the First 6 Months Post-pediatric Heart Transplantation

    J. Chen1, D. Salerno2, H. Corbo1, S. Shah3, A. Rothkopf4, I. D. Lytrivi4

  • Biomarkers of Kidney Injury and Repair in Expanded-Criteria Deceased Donor Kidney Transplant Recipients: A Prospective Study

    A. Al Jurdi1, O. Efe1, B. Aoyama2, M. Lima2, H. Silva2, I. Schmidt3, S. Waikar3, V. Sabbisetti4, L. V. Riella1

  • Blood Gene Expression and Donor-derived Cell Free DNA for Diagnosing Subclinical Acute Rejection in Stable Kidney Transplant Recipients

    S. Park1, K. Guo2, H. Raymond3, E. Poggio4, D. Taber5, C. Marsh6, S. Kurian7, S. Kleiboeker8, J. Weems8, J. Holman9, L. Zhao2, R. Sinha8, S. Brietigam2, C. Rebello2, M. Abecassis10, J. Friedewald1

  • Brain Natriuretic Peptide and Pedometer Activity are Most Predictive of Poor Kidney Transplant Waitlist Outcomes

    P. Manay1, P. TenEyck2, R. Kalil3, M. Sanders4, M. Swee4, G. Binns5, J. Hornikel5, D. Katz1

  • Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the US

    K. A. Agarwal1, H. Patel1, N. Agrawal1, F. Cardarelli1, N. Goyal2

  • Cellular and Genetic Signatures of Operational Tolerance in Kidney Transplant Recipients Through Single Cell R N A Sequencing Analysis

    H. BAE1, H. Lee2, J. Ryu3, B. Chung2, E. Oh3

  • Characteristics, Risk Factors, and Outcomes of Neutropenia for the First Year After Liver or Kidney Transplantation in Children

    C. Jarasvaraparn1, S. Choudhury2, C. Rusch2, K. Liss1, J. Stoll1, S. Hmiel3, S. Kulkarni1

  • Combined Donor Derived Cell Free DNA (AlloSure) and Peripheral Immune Cell Gene Expression (AlloMap) Testing for the Diagnosis of Rejection in Kidney Transplant Recipients with De Novo Donor Specific Antibodies

    K. R. Degner, S. Parajuli, F. Aziz, N. Garg, D. Mandelbrot, M. Mohamed, K. Van Hyfte, S. R. Reese, N. A. Wilson, A. Djamali

  • Comparative Proteomics Analysis Identifies the Biomarker of Ischemia-Reperfusion Injury During Liver Transplantation

    M. Chen1, L. Xiaohong2, H. Xitao1, J. Weiqiang1

  • Comparison of Donor-derived Cell Free Dna Between Recipients with First Solitary Allograft and Regrafts

    S. Paluri1, S. Muthusamy1, M. Shinbashi1, G. Gupta1, B. Dale2, Z. Kashi3, P. Halloran4, D. Kumar1

  • Comparison of Next Generation Sequencing Donor-derived Cell Free DNA Assay Utilizing Whole Genome Sequencing

    N. Singh1, M. S. Naseer1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

  • Continuation of Immunosuppression After the First Renal Allograft Failure Impacts Panel Reactive Antibody Status During Subsequent Renal Transplantation

    J. Patel1, S. Ali2, M. L. Sanders3, C. P. Thomas3, D. Axelrod3, M. Bilal4, E. H. Field4, S. Kuppachi3

  • Core Signature of Rejection-Specific Cytokines and Chemokines in Heart Biopsies After Transplantation

    L. M. Radomsky1, Y. Scheibner2, J. F. Kuehne1, J. Keil1, K. Beushausen1, K. Ludmilla2, A. Schick2, F. Ius2, G. Warnecke3, C. Bara2, C. S. Falk1

  • De Novo Donor Specific Antibodies After Heart Transplantation in Fontan Patients with Protein Losing Enteropathy

    D. A. Magnetta1, V. Hoch2, D. Pinelli3, M. Monge4, E. Pahl1, P. T. Thrush1

  • Dietary Intake and Mycophenolate Mofetil-related Diarrhea Following Kidney Transplantation

    G. Onyeaghala1, L. Teigen2, B. Guo2, Y. Doronin1, M. Al-Kofahi2, B. Wu2, W. Guan2, C. Staley2, S. Riad2, A. Matas2, R. Remmel2, W. Oetting2, C. Dorr1, P. Jacobson2, A. Israni1

  • Does the Timing of Subclinical Acute Rejection After Kidney Transplant Matter?

    P. Portocarrero1, S. Park2, K. Guo3, L. Zhao3, J. Friedewald2

  • Donor Derived Cell-free-dna (dd-cfdna) as a Surrogate Marker for Kidney Biopsy- Indiana University Transplant Nephrology Experience

    S. Valavoor1, A. Sharfuddin2, G. William3, M. Yaqub1, D. Mishler1, O. Adebiyi2

  • Donor-Derived Cell-Free DNA Performance Characteristics are Similar for Repeat and Primary Kidney Transplant Recipients

    V. R. Peddi1, S. Akkina2, S. C. Jordan3, W. Tian4, Y. Qazi5

  • Dysregulation of Immune Cell Glycolysis and Oxidative Phosphorylation Correlates with Development of Pre-liver Transplant Immune Dysfunction and Post-transplant Mortality

    G. Panayotova1, L. Jin1, A. Lemenze1, S. Simonishvili1, Y. Qin1, L. Minze2, G. Dikdan1, F. Paterno1, X. C. Li2, M. Ghobrial2, J. V. Guarrera1, K. E. Lunsford1

  • Endothelial Glycocalyx Shedding is Associated with Graft Quality During Ex Vivo Lung Perfusion

    K. Noda, B. J. Philips, T. Harano, J. D. Luketich, P. G. Sanchez

  • Estimated GFR by Serum Myo-inositol, Valine, Creatinine, and Cystatin-c Outperforms Current CKD-epi Equations in Renal Transplant Recipients

    J. W. Meeusen1, F. Stammler2, J. Lieske3, M. Grassi2, M. Shah4, E. Schiffer2

  • Evaluation of Meningococcal Vaccine Response Among Solid Organ Transplant Recipients Receiving Eculizumab

    R. Arora1, C. Kane1, K. Cunningham1, M. Ison2

  • Evaluation of Serum Klotho Levels at Early Kidney Post-Transplant

    T. Vazquez-Sanchez1, J. Alonso-Titos1, M. Sánchez-Niño2, E. Sola1, M. Leon3, V. Lopez1, P. Ruiz-Esteban1, E. Porrini4, A. Ortiz5, D. Hernández1

  • GENiE in a Bottle – Renasight Testing in the Kidney Transplant Setting – A Single Center Experience

    Y. A. Qazi1, W. Mon1, N. Ioannou2, M. Smogorzewski1

  • Gene Expression Profiles Assessed by the Nanostring nCounter® Platform May Differentiate Different Types of Rejection, and Importantly, T-Cell Mediated Rejection from BK Virus Nephropathy

    K. R. Degner1, K. J. Swanson1, S. Parajuli1, D. Mandelbrot1, N. Garg1, F. Aziz1, M. Mohamed1, W. Zhong1, L. Ptak1, N. A. Wilson1, R. Woodward2, A. Djamali1

  • Hla-dq Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation and Acute Cellular Rejection After Living Donor Liver Transplantation

    K. Ono, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, N. Tanimine, S. Akimoto, Y. Imaoka, K. Sato, H. Yamane, N. Tsukiyama, R. Ide, T. Mochizuki, H. Ohdan

  • Identification and Validation of a Prognostic Index for Renal Allograft Survival Based on the Geo Database

    X. Zhang, Z. Wang, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Immunosuppression Impacts Panel Reactive Antibody Status in Second Solid Organ Transplant Recipients – A Single Center Experience

    J. Patel1, S. Ali2, M. L. Sanders1, C. P. Thomas1, D. Axelrod1, M. Bilal3, E. H. Field3, S. Kuppachi1

  • Immunosuppression is Not Associated with High-risk Immunologic Parameters in Transplant Recipients with the Sars-cov2 Virus

    S. Merl, R. Jones, B. Shonts, D. Rust, M. Sykes, J. Weiner

  • Impact of Deceased Donor Mode of Death and Kidney Donor Profile Index on Baseline Donor Derived Cell Free DNA in Kidney Transplant Recipients

    B. Chopra, A. Grazier, K. K. Sureshkumar

  • Incidence of Pancreatic Exocrine Insufficiency in Patients Undergoing Liver Transplantation

    J. Klein1, M. Rangel1, I. Ifearulundu1, Y. Gely1, Z. Spigel2, S. Janardhan3, M. Hertl1, E. Chan1

  • Initial Experience with TrugrafTm Gene Expression Profile and TracTm Dd-cfdna Testing in Kidney Transplant Recipients Suggests Synergy and Enhanced Management within the First Year Post-transplant and Beyond

    V. Paramasivam, B. Greco, M. Germain

  • Intraoperative Fluid Management and Kidney Transplantation Outcomes: A Retrospective Review

    M. W. Harbell1, M. B. Kraus1, S. A. Buckner Petty2, J. W. Harbell3

  • Is Subclinical Allograft Rejection by 2019 Banff Criteria Associated with Worse Kidney Allograft Outcomes? Comparison Between 2007 and 2019 Banff Criteria

    M. T. Victor1, S. Park2, K. Guo1, L. Zhao1, J. Friedewald3

  • Kidney Graft Biopsy for Indication Proteinuria: Finding, and Outcomes

    S. Parajuli, K. Swanson, J. Alstott, F. Aziz, N. Garg, W. Zhong, A. Djamali, D. Mandelbrot

  • Kidney Injury in Hematopoietic Cell Transplant (HCT) Recipients: Urinary Biomarkers to the Rescue

    T. Salinas1, C. Snopkowski1, C. Li1, K. Chen1, M. Lubetzky1, S. Salvatore1, K. Van Besien1, E. Jaimes2, S. Hingorani3, S. Seshan1, T. Muthukumar1

  • Leukopenia in the Renal Transplant Population

    A. Johnson1, G. Karadkhele2, C. Larsen1

  • Long-term Outcomes of Early Steroid Withdrawal (SW) After Kidney Transplant

    D. Vock1, A. Matas2

  • Longitudinal Surveillance, Relative Change Value (RCV) Improve Diagnostic Test Accuracy (DTA) of Donor-Derived Cell Free DNA (dd-cfDNA)

    S. Anand, F. Lopez-Verdugo, J. Sanchez-Garcia, L. Dong, M. Fife, J. Krong, D. Morris, T. Srinivas

  • Longitudinal Variance of Donor Derived Cell Free DNA (dd-cf DNA) in Stable Kidney Transplant (Tx) Patients are Influenced by Donor/Recipient Variables

    S. Anand, F. Lopez-Verdugo, J. Sanchez-Garcia, L. Dong, M. Fife, J. Krong, D. Morris, T. Srinivas

  • Nomogram of Quantity of Peripheral Cxcr5+Cd8+ T Cells, Aims to Predict Risk of De Novo Dsa in First-time Kidney Transplant Recipients

    J. Zimmerer1, M. Abdel-Rasoul2, G. Bumgardner1

  • Nonadherence Post-kidney Transplant is Associated with Increased Immune Activation Detected by Peripheral Blood Gene Expression Assay

    N. Singh1, A. Palermini1, M. S. Naseer1, T. Le1, S. Tandukar1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

  • Nrf2 Assessment in Discarded Liver Allografts: A Role in Allograft Function and Salvage

    O. Ahmed, M. Xu, F. Zhou, A. N. Wein, G. Upadhya, Y. Lin, W. Chapman

  • Outcomes of Novel Coronavirus 2019 in Solid Organ Transplant Recipients: Yet Again, Race and Payor Status Matters

    C. Huang1, M. Hemmersbach-Miller1, M. Goss2, N. Moreno3, A. Rana1, J. Goss1, N. Galvan1

  • Precision Medicine in Renal Transplantation: T-cell Repertoire Sequencing to Define Donor-specific Clones for Post-transplant Monitoring

    K. R. Sherwood1, P. Wong1, F. Fenninger1, V. Wu1, J. Beckrud2, D. P. Cina3, L. Allan2, J. Lan2, P. A. Keown2

  • RNA Sequencing (RNAseq) Tissue Analysis Can Provide Early Warning Signals for Potential Intestinal Transplant Complications

    J. Kang1, L. Belyayev1, O. Aguirre1, K. Khan1, Y. Gusev2, K. Bhuvaneshwar2, H. Ressom3, J. Hawksworth1, C. Matsumoto1, T. Fishbein1, A. Kroemer1

  • Real-time Donor-derived Cell-free Dna Kinetics Indicate Decreased “Molecular Injury” During Treatment of Acute Renal Allograft Rejection

    R. Hinojosa1, K. M. Hitchman2, D. J. Ross3, R. C. Hall1, J. E. Nelson1, E. L. Kincaide1, K. Klein1, A. M. Bell3

  • Remote Monitoring Using Mobile Phlebotomy and Donor-derived Cell-free DNA in Kidney Transplant Recipients During the Covid-19 Pandemic

    N. Ali1, J. Miles2, V. Tatapudi1, R. Montgomery1

  • Renal Tubular-cell-specific Urinary Extracellular Vesicles: A Novel Biomarker for Diabetic Nephropathy After Kidney Transplantation

    N. Eguchi1, H. Lau1, F. Zaldivar2, U. G. Reddy3, E. Tantisattamo3, A. Ferrey3, D. Dafoe1, H. Ichii1

  • Role of Trugraf Testing in Kidney Allografts Previously Biopsied for Dysfunction

    Y. A. Qazi1, W. Mon1, C. Choi1, S. Qazi2, M. Smogorzewski1

  • Should We Worry About Covid-19 Infection in Pediatric SOT?

    U. Ekong1, S. Paul1, S. Royal2, J. Chahine3, N. Yazigi1, S. Kaufman1, K. Khan1, C. Matsumoto1, A. Kroemer1, T. Fishbein1

  • Single Center Experience Comparing Two Clinically Available Donor Derived Cell Free DNA Tests

    S. Bunnapradist1, S. Lee2, P. Homkrailas3, G. Danovitch3

  • The Assesment of Pre-transplant Donor-reactive IL-21 Producing T Cells as a Tool to Identify Patients at Risk for Acute Rejection

    A. Mendoza Rojas1, T. van Gelder2, R. de Kuiper1, D. Reijerkerk1, M. C. Clahsen-van Groningen3, D. A. Hesselink1, C. C. Baan1, N. M. van Besouw1

  • The Impact of Maintenance Immunosuppression Withdrawal on Sensitization Status After Renal Graft Failure

    R. Hod Dvorai, A. Almonte, C. Hubbell, M. Laftavi, R. Shahbazov, R. Saidi, O. Pankewycz, J. Leggat, M. Hanlon, B. Gallay

  • The Role of the B2 Microglobulin Trend in Patients with Delayed Graft Function After Kidney Transplant

    A. Perez-Gutierrez, P. J. Bachul, B. Juengel, P. Witkowski, D. DiSabato, R. Barth, J. Fung, Y. Becker

  • Torque Teno Virus Load Predicts Allograft Rejection but Not Viral Infection After Kidney Transplantation; A Cohort Joint Modelling Study

    A. L. van Rijn1, H. F. Wunderink2, I. A. Sidorov1, C. S. de Brouwer1, A. C. Kroes1, H. Putter3, A. P. de Vries4, J. I. Rotmans4, M. C. Feltkamp1

  • Tru and Sure -A Tale of Two Cities! Can Allosure Predict and Enhance Trugraf Results?

    Y. A. Qazi1, W. Mon1, S. Qazi2, C. Choi1, M. Smogorzewski1

  • Trugraf Gene Expression Testing Can Discriminate Rejection in the Setting of Acute Kidney Injury

    N. Singh1, M. S. Naseer1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

  • Urinary Exosome Mrna Signature for the Diagnosis of Human Kidney Transplant Rejection

    R. El Fekih1, J. Hurley2, V. Tadigotla2, A. Alghamdi3, A. Srivastava4, C. Coticchia2, J. Choi1, H. Allos5, k. yatim5, J. Alhaddad5, S. Eskandari5, P. Chu5, A. Mihali5, I. Lape5, M. Lima Filho5, B. Ayoma5, A. Chandraker5, K. Safa6, J. Markmann6, L. Riella6, R. Formica7, J. Skog2, J. Azzi5

« View all sessions from the 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences